title: Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine.
authors.affiliation: Heart Transplant Program, Hospital Juan Canalejo, La Coruña, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: Rodríguez
authors.forename: M G
authors.initials: MG
authors.lastname: Crespo-Leiro
authors.forename: M J
authors.initials: MJ
authors.lastname: Paniagua
authors.forename: J J
authors.initials: JJ
authors.lastname: Cuenca
authors.forename: L F
authors.initials: LF
authors.lastname: Hermida
authors.forename: A
authors.initials: A
authors.lastname: Juffé
authors.forename: A
authors.initials: A
authors.lastname: Castro-Beiras
mesh_terms: D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012189:Retrospective Studies; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000453:epidemiology
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D002784:Cholesterol